Esophageal Cancer (ESCR)

Alias:

Esophageal Carcinoma

Carcinoma of Esophagus

Esophageal Squamous Cell Carcinoma, Somatic

Esophageal Carcinoma, Somatic

Gastric Cardia Adenocarcinoma

Esophageal Neoplasms

Malignant Tumor of the Middle Third of the Esophagus

Malignant Neoplasm of Proximal Third of Esophagus

Malignant Neoplasm of Middle Third of Oesophagus

Malignant Neoplasm of Distal Third of Esophagus

Malignant Neoplasm of Lower Third of Oesophagus

Malignant Neoplasm of Middle Third of Esophagus

Malignant Tumor of Proximal Third of Esophagus

Malignant Tumor of Distal Third of Esophagus

Malignant Neoplasm of Upper Third Esophagus

Malignant Tumor of Abdominal Esophagus

Squamous Cell Carcinoma of Esophagus

Esophageal Squamous Cell Carcinoma

Malignant Neoplasm of Esophagus

Malignant Tumor of Esophagus

Esophageal Cancer, Somatic

Ca Middle Third Oesophagus

Aerodigestive Tract Cancer

Ca Lower Third Oesophagus

Carcinoma of Oesophagus

Cancer of Oesophagus

Cancer of Esophagus

Cancer, Esophageal

Esophagus Cancer

Escc

Escr

Favorite

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Esophageal Cancer, also known as esophageal carcinoma, is related to esophagus squamous cell carcinoma and head and neck cancer, and has symptoms including abdominal pain, constipation and coughing. An important gene associated with Esophageal Cancer is TGFBR2 (Transforming Growth Factor Beta Receptor 2), and among its related pathways/superpathways are CKAP4 signaling pathway map and Epithelial to mesenchymal transition in colorectal cancer. The drugs Fentanyl and Lidocaine have been mentioned in the context of this disorder. Affiliated tissues include lymph node and lung, and related phenotypes are esophageal carcinoma and Increased shRNA abundance (Z-score > 2)

Related ID：

MALACARDS：ESP021

OMIM：133239

MESH：D004938